Form 4 for MXCT MAXCYTE, INC.
Accepted 2025-06-23 00:00:00 ET · period of report 2025-06-18 · accession 0000905148-25-002229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-23 | 2025-06-18 | MXCT | BALTHROP PATRICK J | Dir | A - Grant | $0.00 | +29.2K | 50.6K | +137% | $0 |
| D | 2025-06-23 | 2025-06-18 | MXCT | BALTHROP PATRICK J | Dir | A - Grant | $0.00 | +50.8K | 50.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-18 | A | A | 29,210 | $0.00 | 50,577 | D | — | — | (F2) This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date. (F1) These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Derivative | Stock Option (right to buy) | 2025-06-18 | A | A | 50,790 | $0.00 | 50,790 | D | $2.11 · — to 2035-06-17 | 50,790 Common Stock | (F2) This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date. |